Article
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival.
Oncotarget - 30 Jul 2015
Visco Carlo, Falisi Erika, Young Ken H, Pascarella Michela, Perbellini Omar, Carli Giuseppe, Novella Elisabetta, Rossi Davide, Giaretta Ilaria, Cavallini Chiara, Scupoli Maria Teresa, De Rossi Anita, D'Amore Emanuele Stefano Giovanni, Rassu Mario, Gaidano Gianluca, Pizzolo Giovanni, Ambrosetti Achille, Rodeghiero Francesco
Abstract excerpt
The relation between Epstein-Barr virus (EBV) DNA load and clinical course of patients with chronic lymphocytic leukemia (CLL) is unknown. We assessed EBV DNA load by quantitative PCR at CLL presentation in mononuclear cells (MNC) of 220 prospective patients that were enrolled and followed-up in two major Institutions. In 20 patients EBV DNA load was also assessed on plasma samples. Forty-one age-matched healthy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
